Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Mineral Density in Older HIV-1 Infected Subjects on TDF-Based vs Non-TDF Regimens
2011-004420-35Phase 4Completed
- Sponsor
- Gilead Sciences
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in Human immunodeficiency virus infection type 1 (2 cohorts), sponsored by Gilead Sciences. Primary endpoints: Femoral neck T-score and Spine L1-L4 T-score. Started Dec 2012; status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2011-004420-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004420-35.